COCP – cocrystal pharma, inc. (US:NASDAQ)
Stock Stats
News
Cocrystal Pharma Receives IRB Approval from Emory University School of Medicine for Phase 1b Human Challenge Study with CDI-988 for Prevention and Treatment of Norovirus [Yahoo! Finance]
Cocrystal Pharma Receives IRB Approval from Emory University School of Medicine for Phase 1b Human Challenge Study with CDI-988 for Prevention and Treatment of Norovirus
Cocrystal Pharma to Present at the Noble Capital Markets' 21st Emerging Growth Equity Conference [Yahoo! Finance]
Cocrystal Pharma to Present at the Noble Capital Markets’ 21st Emerging Growth Equity Conference
Cocrystal Pharma (NASDAQ:COCP) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.
Form 8-K Cocrystal Pharma, Inc. For: Jan 09
Form 4 Cocrystal Pharma, Inc. For: Jan 09 Filed by: Kornberg Roger D.
Form 4 Cocrystal Pharma, Inc. For: Jan 09 Filed by: Lee Sam
Form 4 Cocrystal Pharma, Inc. For: Jan 09 Filed by: FROST PHILLIP MD ET AL
Form 4 Cocrystal Pharma, Inc. For: Jan 09 Filed by: Hassan Fred
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.